Helen Yull

805 total citations
17 papers, 469 citations indexed

About

Helen Yull is a scholar working on Molecular Biology, Neurology and Nutrition and Dietetics. According to data from OpenAlex, Helen Yull has authored 17 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Nutrition and Dietetics. Recurrent topics in Helen Yull's work include Prion Diseases and Protein Misfolding (13 papers), Neurological diseases and metabolism (7 papers) and Trace Elements in Health (5 papers). Helen Yull is often cited by papers focused on Prion Diseases and Protein Misfolding (13 papers), Neurological diseases and metabolism (7 papers) and Trace Elements in Health (5 papers). Helen Yull collaborates with scholars based in United Kingdom, Netherlands and Italy. Helen Yull's co-authors include James W. Ironside, Mark Head, Diane Ritchie, Jan Langeveld, Martin J. Woodward, Andrew J. Roe, David G. Smith, Stuart W. Naylor, David L. Gally and Moira E. Bruce and has published in prestigious journals such as Brain, Molecular Microbiology and American Journal Of Pathology.

In The Last Decade

Helen Yull

15 papers receiving 463 citations

Peers

Countries citing papers authored by Helen Yull

Since Specialization

Citations

This map shows the geographic impact of Helen Yull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Yull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Yull more than expected).

Fields of papers citing papers by Helen Yull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Yull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Yull. The network helps show where Helen Yull may publish in the future.

Co-authorship network of co-authors of Helen Yull

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Yull. A scholar is included among the top collaborators of Helen Yull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Yull. Helen Yull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Enhanced Creutzfeldt‐Jakob disease surveillance in the older population: Assessment of a protocol for screening brain tissue donations for prion disease 2023 ·Brain Pathology ·Alexander Peden, (unknown), Diane Ritchie, Helen Yull, Colin Smith, Lovney Kanguru, Anna Molesworth, Richard Knight, Marcelo A. Barria	2
2	Variably protease‐sensitive prionopathy mimicking frontotemporal dementia 2019 ·Neuropathology ·Miren Aizpurua, (unknown), Helen Yull, Christopher Kipps, James W. Ironside, István Bódi	8
3	Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK 2017 ·Acta Neuropathologica ·Diane Ritchie, P Adlard, Alexander Peden, Suzanne Lowrie, (unknown), (unknown), Rosemary J. Jackson, Helen Yull, Michael J. Keogh, Wei Wei, Patrick F. Chinnery, Mark Head, James W. Ironside	71
4	UK Iatrogenic Creutzfeldt–Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches 2016 ·Acta Neuropathologica ·Diane Ritchie, Marcelo A. Barria, Alexander Peden, Helen Yull, (unknown), P Adlard, James W. Ironside, Mark Head	28
5	Iatrogenic Creutzfeldt-Jakob disease in human growth hormone recipients in the United Kingdom 2016 ·Prion ·Mark Head, Diane Ritchie, Helen Yull, Alexander Peden, James W. Ironside	0
6	Variably protease-sensitive prionopathy in the UK: a retrospective review 1991–2008 2013 ·Brain ·Mark Head, Helen Yull, Diane Ritchie, Jan Langeveld, Nicholas Fletcher, Richard Knight, James W. Ironside	34
7	UNRAVELLING THE MYSTERIES OF SPORADIC CJD 2013 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Helen Yull, James W. Ironside, Mark Head, Richard Knight	1
8	Comparison of two different protocols for the detection of PrPres type 1 and 2 co-occurrence in sporadic CJD 2012 ·Prion ·Mark Head, Helen Yull, (unknown), Diane Ritchie, Matthew Bishop, Richard Knight, James W. Ironside	1
9	Variably protease sensitive prionopathy in the United Kingdom 2012 ·Clinical Neuropathology ·Mark Head, Helen Yull, Diane Ritchie, Matthew Bishop, Richard Knight, James W. Ironside	1
10	A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann–Sträussler–Scheinker disease phenotype: comparison with similar cases from the literature 2010 ·Acta Neuropathologica ·Casper Jansen, (unknown), Mark Head, Piero Parchi, Helen Yull, Aad Verrips, Pieter Wesseling, Jan Meulstee, Frank Baas, Willem A. van Gool, James W. Ironside, Annemieke J.M. Rozemüller	25
11	The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype 2010 ·Journal of Neurology Neurosurgery & Psychiatry ·Casper Jansen, Mark Head, Willem A. van Gool, Frank Baas, Helen Yull, James W. Ironside, Annemieke J.M. Rozemüller	32
12	Further characterisation of the prion protein molecular types detectable in the NIBSC Creutzfeldt–Jakob disease brain reference materials 2009 ·Biologicals ·Helen Yull, James W. Ironside, Mark Head	9
13	Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP^Sc) associated with variant Creutzfeldt‐Jakob disease 2009 ·Transfusion ·M. G. K. Jones, Alexander Peden, Helen Yull, Darren J. Wight, Matthew Bishop, C. V. Prowse, Marc Turner, James W. Ironside, Ian MacGregor, Mark Head	32
14	Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrPSc) associated with variant Creutzfeldt-Jakob disease 2008 ·Prion ·Alexander Peden, M. G. K. Jones, Helen Yull, Darren J. Wight, Matthew Bishop, (unknown), Marc Turner, James W. Ironside, Ian MacGregor, Mark Head	0
15	Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease 2006 ·American Journal Of Pathology ·Helen Yull, Diane Ritchie, Jan Langeveld, F.G. van Zijderveld, Moira E. Bruce, James W. Ironside, Mark Head	97
16	Co‐ordinate single‐cell expression of LEE4‐ and LEE5‐encoded proteins of Escherichia coli O157:H7 2004 ·Molecular Microbiology ·Andrew J. Roe, Stuart W. Naylor, Kevin Spears, Helen Yull, (unknown), (unknown), Iain J. McKendrick, Megan E. Porter, Martin J. Woodward, David G. Smith, David L. Gally	48
17	Heterogeneous Surface Expression of EspA Translocon Filaments by Escherichia coli O157:H7 Is Controlled at the Posttranscriptional Level 2003 ·Infection and Immunity ·Andrew J. Roe, Helen Yull, Stuart W. Naylor, Martin J. Woodward, David G. Smith, David L. Gally	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact